What are the outcomes of monitoring with repeated biomarker measurement (BNP, NT-proBNP or troponin) or repeated cardiac imaging (echocardiography or cardiac MRI), compared to usual care without repeated measurement or imaging?
The outcomes of monitoring with repeated biomarker measurement (BNP, NT-proBNP or troponin) or repeated cardiac imaging (echocardiography or cardiac MRI), compared to usual care without repeated measurement or imaging include CRITICAL outcomes such as mortality (time to event), quality of life at 12 months (continuous) and unplanned hospitalisation (all-cause) (count rate), as well as IMPORTANT outcomes such as adverse events - hypotension (dichotomous), adverse events - hyperkalaemia (dichotomous), adverse events - renal function (continuous), adverse events - bradycardia (dichotomous) and adverse events - arrhythmic events (dichotomous).